NCT03699696

Brief Summary

This study proposes to perform a pilot observational study looking at the doses of propofol used for the induction of general anesthesia and its association with the development of hypotension and AKI among elderly patients at YNHH.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
541

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 8, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 8, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 5, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 9, 2018

Completed
Last Updated

January 24, 2019

Status Verified

January 1, 2019

Enrollment Period

3.6 years

First QC Date

October 5, 2018

Last Update Submit

January 22, 2019

Conditions

Keywords

acute kidney injuryhypotensionanesthetic dosinginductionelderly

Outcome Measures

Primary Outcomes (1)

  • Overdose

    Percentage of patients \>=65 who received greater than the FDA approved induction dosage of propofol

    Between time of induction of anesthesia and surgical incision as detailed in the patient's anesthesia record

Secondary Outcomes (2)

  • Hypotension

    Between time of induction of anesthesia and surgical incision as detailed in the patient's anesthesia record

  • Acute kidney injury

    Within 7 days postoperatively

Study Arms (3)

65-75 years of age

Patients who are between the ages of 65 and 75, including 65 but not including 75, and receive propofol for induction of anesthesia.

Drug: Propofol

75-85 years of age

Patients who are between the ages of 75 and 85, including 75 but not including 85, and receive propofol for induction of anesthesia.

Drug: Propofol

85+ years of age

Patients who are 85 years of age or older, and receive propofol for induction of anesthesia.

Drug: Propofol

Interventions

Induction of anesthesia prior to surgery with propofol

Also known as: Diprivan
65-75 years of age75-85 years of age85+ years of age

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who underwent induction of general anesthesia at YNHH, looking specifically at elderly patients undergoing gynecology-oncology surgeries with intubation and propofol induction.

You may qualify if:

  • Patients age 65 or older who underwent induction of general anesthesia at YNHH
  • Only first surgery for each patient within the time period is counted
  • Only include patients who underwent intubation
  • Only include patients who underwent induction by propofol bolus
  • Only include patients who got at least 0.3mg/kg of propofol

You may not qualify if:

  • Patients under the age of 65, patients who underwent monitored anesthetic care/conscious mediation for their procedures.
  • Patients with renal failure and/or chronic kidney disease
  • Patients who have a pre-operative systolic blood pressure \<100

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale New Haven Health System

New Haven, Connecticut, 06511, United States

Location

Related Publications (1)

  • Chen EY, Michel G, Zhou B, Dai F, Akhtar S, Schonberger RB. An Analysis of Anesthesia Induction Dosing in Female Older Adults. Drugs Aging. 2020 Jun;37(6):435-446. doi: 10.1007/s40266-020-00760-3.

MeSH Terms

Conditions

Acute Kidney InjuryHypotension

Interventions

Propofol

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Eric Y Chen, BS

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 5, 2018

First Posted

October 9, 2018

Study Start

December 1, 2014

Primary Completion

July 8, 2018

Study Completion

July 8, 2018

Last Updated

January 24, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations